Skip to main content

Table 2 Patient-related outcomes of all patients during 1 year of follow-up a

From: Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study

 

Early remission

Arm 1

Arm 2

 

OP group

Patient characteristics at follow-up visits

(N = 387)

(N = 83)

(N = 78)

P

(N = 50)

4 months

     

DAS

0.97 (0.40)

2.49 (0.63)

2.57 (0.68)

0.47

2.31 (0.63)

HAQ

0.23 (0.33)

0.86 (0.57)

0.88 (0.57)

0.77

0.73 (0.68)

MACTAR

58.2 (15.7)

52.8 (15.1)

48.9 (18.8)

0.14

51.6 (14.1)

MCS

52.4 (8.0)

48.8 (9.9)

50.7 (10.8)

0.26

49.8 (10.5)

PCS

51.7 (8.1)

39.4 (9.7)

38.1 (9.4)

0.44

42.5 (9.4)

VASgl, mm

14 (14)

37 (21)

39 (21)

0.61

28 (22)

VASda, mm

12 (15)

42 (24)

43 (24)

0.74

32 (25)

VASpain, mm

10 (14)

39 (24)

38 (24)

0.79

27 (24)

VASms, mm

11 (17)

40 (27)

39 (27)

0.78

32 (30)

8 months

     

DAS

1.29 (0.69)

1.97 (0.87)

2.01 (0.91)

0.77

2.02 (0.84)

HAQ

0.35 (0.44)

0.74 (0.61)

0.81 (0.64)

0.51

0.68 (0.59)

MACTAR

56.4 (15.7)

55.8 (14.7)

54.5 (16.1)

0.60

48.9 (19.9)

MCS

52.9 (8.4)

46.6 (17.9)

48.7 (10.3)

0.85

48.5 (13.0)

PCS

48.9 (9.1)

42.8 (10.9)

42.5 (11.0)

0.26

43.7 (9.5)

VASgl, mm

20 (20)

33 (23)

34 (21)

0.75

30 (23)

VASda, mm

22 (23)

39 (26)

33 (24)

0.20

35 (25)

VASpain, mm

19 (23)

35 (26)

31 (25)

0.36

32 (24)

VASms, mm

24 (26)

34 (29)

37 (28)

0.51

40 (27)

1 year

     

DAS

1.31 (0.78)

2.07 (0.89)

1.77 (0.90)

0.04

2.20 (0.83)

HAQ

0.38 (0.49)

0.87 (0.66)

0.81 (0.66)

0.60

0.77 (0.65)

MACTAR

63.0 (9.4)

59.2 (10.3)

60.4 (11.9)

0.54

59.7 (11.21)

MCS

53.1 (8.6)

50.5 (10.3)

50.5 (10.1)

0.97

50.4 (11.9)

PCS

48.6 (9.8)

39.9 (10.3)

43.0 (11.4)

0.10

42.6 (10.9)

VASgl, mm

20 (21)

33 (23)

27 (20)

0.10

33 (24)

VASda, mm

24 (26)

42 (29)

31 (26)

0.02

34 (27)

VASpain, mm

21 (23)

38 (28)

28 (25)

0.02

28 (25)

VASms, mm

25 (26)

41 (31)

33 (27)

0.96

39 (30)

Remission (DAS <1.6)

263 (68)

21 (25)

32 (41)

0.01

11 (22)

  1. aData are means ± SD, medians (IQR) or numbers (%) as appropriate. ACPA: anticitrullinated protein antibody; DAS: Disease Activity Score; HAQ: Health Assessment Questionnaire; MACTAR: McMaster Toronto Arthritis Patient Preference Questionnaire; MCS: Mental Component Score on the 36-Item Short Form Health Survey; PSC: Physical Component Score on the 36-Item Short Form Health Survey; RA2010: rheumatoid arthritis according to the 2010 American College of Rheumatology and European League against Rheumatism classification criteria; VASda: disease activity; VASgl: global health; VASms: morning stiffness; VASpain: pain. P-value represents the difference in mean scores and remission rates between arms 1 and 2.